AFib screening using wearable devices found to be cost-effective for patients as young as 50

Cardiovascular Business August 12, 2022
Jessica Kania

In a massive simulation exercise, researchers recently found that using wrist-worn wearable devices to screen people for atrial fibrillation (AFib) may be more cost-effective than traditional modalities such as pulse palpation and 12-lead electrocardiograms.

Additionally, they found that the devices could potentially be cost-effective for younger age groups than the traditionally recommended age group for AFib monitoring, 65 and above.

Their results were published in Jama Health Forum. Read more on two of their key findings below:

1. Wearable devices may be more cost-effective than traditional AFib detection modalities.

Specifically, the study examined the costs and benefits of six different wearable devices for a simulated population of 30 million people, with ages and comorbidities matching the actual...

Today's Sponsors

Today's Sponsor